KARUNA THERAPEUTICS INC's ticker is KRTX and the CUSIP is 48576A100. A total of 201 filers reported holding KARUNA THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 1.18 and the average weighting 0.9%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $5,449,200 | -94.6% | 30,000 | -94.2% | 2.63% | -89.8% |
Q4 2022 | $100,779,348 | -65.9% | 512,872 | -60.9% | 25.81% | -32.6% |
Q3 2022 | $295,304,000 | -19.9% | 1,312,872 | -54.9% | 38.28% | -14.7% |
Q2 2022 | $368,507,000 | -0.2% | 2,912,872 | 0.0% | 44.90% | -14.9% |
Q1 2022 | $369,323,000 | -3.2% | 2,912,872 | 0.0% | 52.78% | +30.7% |
Q4 2021 | $381,586,000 | – | 2,912,872 | – | 40.37% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Pivotal bioVenture Partners Investment Advisor LLC | 782,008 | $142,043,933 | 58.49% |
Nan Fung Group Holdings Ltd | 225,688 | $40,993,968 | 27.90% |
Sofinnova Investments, Inc. | 1,773,124 | $322,070,243 | 20.60% |
Artia Global Partners LP | 88,831 | $16,135,263 | 5.96% |
DAFNA Capital Management LLC | 78,573 | $14,272,000 | 4.28% |
First Light Asset Management, LLC | 243,675 | $44,261,127 | 3.98% |
CATALYST PRIVATE WEALTH, LLC | 21,837 | $3,966,473 | 2.74% |
Sands Capital Ventures, LLC | 58,895 | $10,697,688 | 2.64% |
ARCH Venture Management, LLC | 30,000 | $5,449,200 | 2.63% |
Logos Global Management LP | 100,000 | $18,164,000 | 2.60% |